CVI Investments, Inc. 13D/13G Filings for ReShape Lifesciences Inc. (RSLS)

CVI Investments, Inc. 13D and 13G filings for ReShape Lifesciences Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-05-12
12:11 pm
Sale		 2025-03-31 13G ReShape Lifesciences Inc.
RSLS		 CVI Investments, Inc. 200,000
5.700%		 -144,626decrease
(-41.97%)		 Filing
2025-02-21
10:33 am
Purchase		 2025-02-18 13G ReShape Lifesciences Inc.
RSLS		 CVI Investments, Inc. 13,785
9.900%		 13,785increase
(New Position)		 Filing